Aclaris Therapeutics Cash Flow Statement (2014-2026) | ACRS

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)	-35.52M	-38.44M	-184.94M	-38.01M	-32.16M	-36.39M	-213.20M	-34.12M	-39.00M	-32.94M	-1.87M	-17.43M	-11.46M	-9.66M	-108.29M	-18.49M	-18.87M	-19.19M	-31.32M	-37.46M
Depreciation and Depletion (Quarter)	0.20M	0.20M	0.20M	0.20M	0.20M	0.20M	0.10M	0.20M	0.20M	0.20M	0.20M	0.20M	0.20M	0.20M	0.10M	0.10M	0.10M	0.10M
Share-based Compensation (Quarter)	3.83M	3.70M	3.85M	2.35M	3.69M	4.19M	4.81M	6.81M	6.52M	5.95M	-19.28M	2.09M	2.90M	3.00M	-0.45M	0.28M	14.00M	2.86M	2.93M	19.70M
Gains from Investment Securities (Quarter)	4.80M	0.90M	2.20M	-1.20M	-3.40M	2.20M	7.10M	-0.80M	-1.50M	1.70M	-26.30M	2.80M	0.20M	0.80M	-1.30M	0.30M	1.50M	0.10M	0.40M
Asset Writedowns and Impairment (Quarter)											6.60M
Cash from Restructuring (Quarter)
Cash from Operations (Quarter)	-12.22M	-10.61M	-17.07M	-20.97M	-19.67M	-7.82M	-19.11M	-26.35M	-20.65M	-24.56M	-6.76M	-20.82M	-12.32M	22.00M	-8.94M	-13.06M	-9.99M	-10.93M	-13.13M	-18.15M
Depreciation, Depletion & Amortization
Amortization of Goodwill (Quarter)
Depreciation & Amortization (CF) (Quarter)	0.25M	0.19M	0.20M	0.21M	0.21M	0.19M	0.19M	0.20M	0.22M	0.22M	0.23M	0.24M	0.24M	0.18M	0.14M	0.13M	0.11M	0.11M	0.10M	0.10M
Change in Working Capital
Change in Receivables (Quarter)	0.12M	-0.13M	-0.19M	0.01M	0.00M	-0.04M	-0.11M	0.20M	-0.26M	-0.09M	-0.05M	0.07M	-0.05M	0.02M	-0.03M	-0.07M	-0.06M
Change in Inventory (Quarter)
Change in Account Payables (Quarter)	-3.13M	2.58M	2.36M	-1.86M	-2.42M	1.96M	2.69M	-2.16M	3.23M	-2.15M	-0.39M	1.93M	-3.54M	0.39M	-2.97M	1.66M	2.44M	0.38M	3.96M	1.51M
Change in Accured Expenses (Quarter)	3.29M	-2.93M	2.54M	-1.85M	1.67M	1.45M	-0.68M	-1.16M	0.92M	6.59M	5.64M	-12.91M	-1.46M	-1.15M	11.57M	-11.04M	0.40M	1.29M	1.25M	-3.03M
Other Working Capital Changes (Quarter)	2.97M	-5.21M	5.61M	-0.19M	-1.12M	-2.10M	5.70M	0.87M	0.73M	7.69M	-7.98M	-2.04M	-0.27M	-1.43M	8.60M	-8.21M	1.18M
Investing Activities
Capital Expenditures (Quarter)		0.06M	0.20M	0.11M	0.24M	0.15M	-0.48M	0.04M	0.35M	-0.02M	0.93M	0.14M	-0.01M			0.04M	0.02M	-0.05M	0.10M	0.06M
Change in Acquisitions & Divestments (Quarter)	16.06M	14.96M	26.32M	44.65M	49.50M	35.00M	48.83M	54.88M	70.56M	49.78M	7.99M	16.97M	34.53M	17.13M	17.51M	29.99M	25.00M	19.05M	15.00M	20.75M
Cash from Investing Activities (Quarter)	-45.47M	-37.67M	-9.18M	29.93M	-21.22M	1.22M	2.70M	25.80M	-19.66M	32.53M	7.55M	16.83M	-0.67M	2.79M	-88.72M	19.12M	5.05M	13.83M	10.37M	-30.93M
Financing Activities
Other financing activities (Quarter)	1.04M			0.04M	0.08M		0.04M			0.01M	0.05M									0.15M
Cash from Financing Activities (Quarter)	135.87M	-11.57M	-0.00M	0.03M	72.81M	-0.01M	0.04M			-0.09M	0.05M	-0.06M	-0.01M	0.02M	74.58M	-0.28M	-0.01M	-3.04M	-2.53M	57.78M
Additional items
Change in Cash (Quarter)	78.18M	-59.84M	-26.25M	8.99M	31.92M	-6.61M	-16.38M	-0.56M	-13.57M	7.89M	0.84M	-4.04M	-13.01M	24.82M	-23.08M	5.79M	-4.96M	-0.15M	-5.30M	8.70M
Free Cash Flow (Quarter)	-12.22M	-10.66M	-17.27M	-21.08M	-19.91M	-7.97M	-18.64M	-26.39M	-21.01M	-24.54M	-7.69M	-20.95M	-12.31M	22.00M	-8.94M	-13.10M	-10.01M	-10.88M	-13.23M	-18.21M
Net Cash Flow (Quarter)	78.18M	-59.84M	-26.25M	8.99M	31.92M	-6.61M	-16.38M	-0.56M	-40.32M	7.89M	0.84M	-4.04M	-13.01M	24.82M	-23.08M	5.79M	-4.96M	-0.15M	-5.30M	8.70M

Research Tools

Developers

Aclaris Therapeutics Cash Flow Statement (2014-2026) | ACRS

Research Tools

Developers

Aclaris Therapeutics Cash Flow Statement (2014-2026) | ACRS

Create an account

Sign In

Reset Password